1
REATA PHARMACEUTICALS INC
CL A
RETA
RETA
1,430,004
$145.8m6.76%
6.76%
Added Shares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.4m
+200.0k
+200,000
16.3%
2
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
1,576,000
$143.6m6.66%
6.66%
Unchanged Shares held: Q3 2022 1.3m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 1.6m
3
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
4,684,264
$125.3m5.81%
5.81%
Unchanged Shares held: Q3 2022 4.0m, Q4 2022 4.0m, Q1 2023 4.7m, Q2 2023 4.7m
4
TYRA BIOSCIENCES INC
COM
TYRA
TYRA
6,448,359
$109.8m5.09%
5.09%
Unchanged Shares held: Q3 2022 6.4m, Q4 2022 6.4m, Q1 2023 6.4m, Q2 2023 6.4m
5
SPRINGWORKS THERAPEUTICS INC
COM
SWTX
SWTX
3,421,541
$89.7m4.16%
4.16%
Unchanged Shares held: Q3 2022 3.4m, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
6
BEIGENE LTD
SPONSORED ADR
ONC
ONC
500,000
$89.2m4.13%
4.13%
Unchanged Shares held: Q3 2022 500.0k, Q4 2022 500.0k, Q1 2023 500.0k, Q2 2023 500.0k
7
AKERO THERAPEUTICS INC
COM
AKRO
AKRO
1,676,733
$78.3m3.63%
3.63%
Added Shares held: Q3 2022 831.5k, Q4 2022 831.5k, Q1 2023 831.5k, Q2 2023 1.7m
+845.2k
+845,238
101.7%
8
MIRATI THERAPEUTICS INC
COM
MRTX
MRTX
2,000,000
$72.3m3.35%
3.35%
Unchanged Shares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
9
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
600,000
$68.7m3.19%
3.19%
Reduced Shares held: Q3 2022 200.0k, Q4 2022 0, Q1 2023 775.0k, Q2 2023 600.0k
-175.0k
-175,000
-22.6%
10
CYTOKINETICS INC
COM NEW
CYTK
CYTK
2,100,000
$68.5m3.18%
3.18%
Unchanged Shares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
11
IMMUNOGEN INC
COM
IMGN
IMGN
2,961,000
$55.9m2.59%
2.59%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.0m
12
KARUNA THERAPEUTICS INC
COM
COM
250,000
$54.2m2.51%
2.51%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 250.0k
13
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
2,202,812
$51.8m2.40%
2.40%
Unchanged Shares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
14
SAGE THERAPEUTICS INC
COM
SAGE
SAGE
1,094,000
$51.4m2.39%
2.39%
Unchanged Shares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
15
NUVALENT INC
COM
COM
1,210,192
$51.0m2.37%
2.37%
Unchanged Shares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
16
MERUS N V
COM
MRUS
MRUS
1,900,000
$50.0m2.32%
2.32%
Unchanged Shares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 1.9m
17
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
2,084,000
$45.0m2.08%
2.08%
Unchanged Shares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
18
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
600,000
$41.4m1.92%
1.92%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 600.0k
19
89BIO INC
COM
ETNB
ETNB
2,100,000
$39.8m1.85%
1.85%
Unchanged Shares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 2.1m, Q2 2023 2.1m
20
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
1,602,200
$32.5m1.51%
1.51%
Added Shares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.6m
+170.0k
+170,000
11.9%
21
IVERIC BIO INC
COM
OPHT
OPHT
825,000
$32.5m1.51%
1.51%
Unchanged Shares held: Q3 2022 0, Q4 2022 825.0k, Q1 2023 825.0k, Q2 2023 825.0k
22
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
2,000,000
$32.4m1.50%
1.50%
Unchanged Shares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 2.0m, Q2 2023 2.0m
23
ARGENX SE
SPONSORED ADR
ARGX
ARGX
75,000
$29.2m1.36%
1.36%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 75.0k
24
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
2,325,000
$29.2m1.35%
1.35%
Unchanged Shares held: Q3 2022 2.3m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.3m
25
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
1,466,051
$29.1m1.35%
1.35%
Unchanged Shares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
26
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
400,000
$28.7m1.33%
1.33%
Unchanged Shares held: Q3 2022 0, Q4 2022 400.0k, Q1 2023 400.0k, Q2 2023 400.0k
27
ITEOS THERAPEUTICS INC
COM
ITOS
ITOS
2,154,058
$28.5m1.32%
1.32%
Unchanged Shares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
28
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
850,000
$27.9m1.29%
1.29%
Unchanged Shares held: Q3 2022 850.0k, Q4 2022 850.0k, Q1 2023 850.0k, Q2 2023 850.0k
29
ANAPTYSBIO INC
COM
ANAB
ANAB
1,300,000
$26.4m1.23%
1.23%
Unchanged Shares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m
30
IOVANCE BIOTHERAPEUTICS INC
COM
IOVA
IOVA
3,705,133
$26.1m1.21%
1.21%
Unchanged Shares held: Q3 2022 1.9m, Q4 2022 1.5m, Q1 2023 3.7m, Q2 2023 3.7m
31
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
7,123,642
$23.6m1.10%
1.10%
Unchanged Shares held: Q3 2022 6.9m, Q4 2022 7.1m, Q1 2023 7.1m, Q2 2023 7.1m
32
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
100,000
$23.1m1.07%
1.07%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.0k
33
XENON PHARMACEUTICALS INC
COM
XENE
XENE
600,000
$23.1m1.07%
1.07%
Unchanged Shares held: Q3 2022 600.0k, Q4 2022 600.0k, Q1 2023 600.0k, Q2 2023 600.0k
34
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
1,819,132
$22.8m1.06%
1.06%
Reduced Shares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 1.8m
-350.0k
-350,000
-16.1%
35
POINT BIOPHARMA GLOBAL INC
COM
COM
2,500,000
$22.6m1.05%
1.05%
Unchanged Shares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
36
EXELIXIS INC
COM
EXEL
EXEL
1,150,000
$22.0m1.02%
1.02%
Unchanged Shares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
37
PROTHENA CORP PLC
SHS
PRTA
PRTA
300,000
$20.5m0.95%
0.95%
Unchanged Shares held: Q3 2022 300.0k, Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k
38
PMV PHARMACEUTICALS INC
COM
PMVP
PMVP
3,163,795
$19.8m0.92%
0.92%
Unchanged Shares held: Q3 2022 3.2m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 3.2m
39
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
1,650,000
$14.8m0.69%
0.69%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.6m, Q2 2023 1.6m
40
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
710,644
$14.5m0.67%
0.67%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 710.6k, Q2 2023 710.6k
41
DAY ONE BIOPHARMACEUTICALS I
COM
COM
1,189,943
$14.2m0.66%
0.66%
Unchanged Shares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
42
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
1,732,571
$13.4m0.62%
0.62%
Added Shares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.7m
+678.6k
+678,571
64.4%
43
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
450,000
$12.7m0.59%
0.59%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 450.0k
44
AVIDITY BIOSCIENCES INC
COM
RNA
RNA
1,121,327
$12.4m0.58%
0.58%
Unchanged Shares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
45
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
1,224,892
$12.2m0.57%
0.57%
Unchanged Shares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
46
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
1,074,082
$11.6m0.54%
0.54%
Unchanged Shares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
47
PRELUDE THERAPEUTICS INC
COM
PRLD
PRLD
2,495,018
$11.2m0.52%
0.52%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 699.0k, Q2 2023 2.5m
+1.8m
+1,795,971
256.9%
48
BLACK DIAMOND THERAPEUTICS I
COM
BDTX
BDTX
2,014,858
$10.2m0.47%
0.47%
Unchanged Shares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
49
GERON CORP
COM
GERN
GERN
3,000,000
$9.6m0.45%
0.45%
New Shares held: Q3 2022 0, Q4 2022 8.1m, Q1 2023 0, Q2 2023 3.0m
50
ASCENDIS PHARMA A/S
SPONSORED ADR
SPONSORED ADR
95,000
$8.5m0.39%
0.39%
Unchanged Shares held: Q3 2022 70.0k, Q4 2022 95.0k, Q1 2023 95.0k, Q2 2023 95.0k
51
CENTESSA PHARMACEUTICALS PLC
SPONSORED ADS
SPONSORED ADS
1,251,137
$7.7m0.36%
0.36%
Unchanged Shares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m
52
CABALETTA BIO INC
COM
CABA
CABA
540,000
$7.0m0.32%
0.32%
Unchanged Shares held: Q3 2022 540.0k, Q4 2022 540.0k, Q1 2023 540.0k, Q2 2023 540.0k
53
COGENT BIOSCIENCES INC
COM
COGT
COGT
525,000
$6.2m0.29%
0.29%
Unchanged Shares held: Q3 2022 425.0k, Q4 2022 525.0k, Q1 2023 525.0k, Q2 2023 525.0k
54
DISC MEDICINE INC
COM
IRON
IRON
130,000
$5.8m0.27%
0.27%
Unchanged Shares held: Q3 2022 0, Q4 2022 130.0k, Q1 2023 130.0k, Q2 2023 130.0k
55
RAPT THERAPEUTICS INC
COM
COM
300,000
$5.6m0.26%
0.26%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 300.0k, Q2 2023 300.0k
56
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
459,836
$4.7m0.22%
0.22%
Unchanged Shares held: Q3 2022 459.8k, Q4 2022 459.8k, Q1 2023 459.8k, Q2 2023 459.8k
57
GOSSAMER BIO INC
COM
GOSS
GOSS
3,336,928
$4.0m0.19%
0.19%
Unchanged Shares held: Q3 2022 3.6m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.3m
58
SELECTA BIOSCIENCES INC
COM
COM
3,284,072
$3.7m0.17%
0.17%
Unchanged Shares held: Q3 2022 3.3m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.3m
59
MERSANA THERAPEUTICS INC
COM
COM
1,000,000
$3.3m0.15%
0.15%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
60
THESEUS PHARMACEUTICALS INC
COM
COM
350,000
$3.3m0.15%
0.15%
Unchanged Shares held: Q3 2022 892.1k, Q4 2022 415.0k, Q1 2023 350.0k, Q2 2023 350.0k
61
MEREO BIOPHARMA GROUP PLC
SPON ADS
MREO
MREO
2,250,000
$3.0m0.14%
0.14%
Unchanged Shares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
62
DBV TECHNOLOGIES S A
SPONSORED ADR
SPONSORED ADR
1,450,000
$2.8m0.13%
0.13%
Unchanged Shares held: Q3 2022 2.1m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m
63
THIRD HARMONIC BIO INC
COM
COM
570,417
$2.7m0.13%
0.13%
Unchanged Shares held: Q3 2022 570.4k, Q4 2022 570.4k, Q1 2023 570.4k, Q2 2023 570.4k
64
FATE THERAPEUTICS INC
COM
FATE
FATE
500,000
$2.4m0.11%
0.11%
Unchanged Shares held: Q3 2022 350.0k, Q4 2022 1.2m, Q1 2023 500.0k, Q2 2023 500.0k
65
ATRECA INC
CL A COM
BCEL
BCEL
2,202,333
$2.2m0.10%
0.10%
Unchanged Shares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
66
BIOATLA INC
COM
BCAB
BCAB
686,347
$2.1m0.10%
0.10%
Unchanged Shares held: Q3 2022 686.3k, Q4 2022 686.3k, Q1 2023 686.3k, Q2 2023 686.3k
67
MILESTONE PHARMACEUTICALS IN
COM
MIST
MIST
698,861
$2.0m0.09%
0.09%
Unchanged Shares held: Q3 2022 698.9k, Q4 2022 698.9k, Q1 2023 698.9k, Q2 2023 698.9k
68
EQRX INC
COM
COM
1,000,000
$1.9m0.09%
0.09%
Unchanged Shares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
69
ORCHESTRA BIOMED HLDGS INC
COM
OBIO
OBIO
250,000
$1.8m0.08%
0.08%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 250.0k, Q2 2023 250.0k
70
KINNATE BIOPHARMA INC
COM
KNTE
KNTE
491,000
$1.5m0.07%
0.07%
Reduced Shares held: Q3 2022 1.5m, Q4 2022 510.0k, Q1 2023 510.0k, Q2 2023 491.0k
-19.0k
-19,000
-3.7%
71
RAIN ONCOLOGY INC
COM
COM
1,152,212
$1.4m0.06%
0.06%
Reduced Shares held: Q3 2022 1.2m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 1.2m
-995.0k
-995,000
-46.3%
72
NGM BIOPHARMACEUTICALS INC
COM
NGM
NGM
500,000
$1.3m0.06%
0.06%
Unchanged Shares held: Q3 2022 500.0k, Q4 2022 500.0k, Q1 2023 500.0k, Q2 2023 500.0k
73
MEI PHARMA INC
COM NEW
MEIP
MEIP
145,654
$958.0k0.04%
0.04%
Reduced Shares held: Q3 2022 2.9m, Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 145.7k
-2.8m
-2,767,437
-95.0%
74
ALAUNOS THERAPEUTICS INC
COM
COM
1,500,000
$765.0k0.04%
0.04%
Unchanged Shares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
75
PROTARA THERAPEUTICS INC
COM STK
TARA
TARA
209,227
$500.0k0.02%
0.02%
Unchanged Shares held: Q3 2022 209.2k, Q4 2022 209.2k, Q1 2023 209.2k, Q2 2023 209.2k
76
VERU INC
COM
COM
347,300
$413.0k0.02%
0.02%
Unchanged Shares held: Q3 2022 2.5m, Q4 2022 347.3k, Q1 2023 347.3k, Q2 2023 347.3k
77
BELLICUM PHARMACEUTICALS INC
COM NEW
BLCM
BLCM
450,000
$167.0k0.01%
0.01%
New Shares held: Q3 2022 57.0k, Q4 2022 57.0k, Q1 2023 0, Q2 2023 450.0k
78
NUVATION BIO INC
*W EXP 07/07/202
NUVB.WS
NUVB.WS
266,666
$44.0k0.00%
0.00%
Unchanged Shares held: Q3 2022 266.7k, Q4 2022 266.7k, Q1 2023 266.7k, Q2 2023 266.7k
79
SURROZEN INC
*W EXP 08/01/203
*W EXP 08/01/203
66,666
$4.0k0.00%
0.00%
Unchanged Shares held: Q3 2022 66.7k, Q4 2022 66.7k, Q1 2023 66.7k, Q2 2023 66.7k